U.S. Crispr And Cas Genes Market Size & Outlook, 2023-2030
U.S. crispr and cas genes market, 2018-2030 (US$M)
Related Markets
U.S. crispr and cas genes market highlights
- The U.S. crispr and cas genes market generated a revenue of USD 1,079.0 million in 2023 and is expected to reach USD 3,146.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 16.5% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
Crispr and cas genes market data book summary
| Market revenue in 2023 | USD 1,079.0 million |
| Market revenue in 2030 | USD 3,146.3 million |
| Growth rate | 16.5% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.0% of the global crispr and cas genes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 528.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. crispr and cas genes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr and cas genes market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 78.74% in 2023. Horizon Databook has segmented the U.S. crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Other factors, such as sophisticated research & medical infrastructure, funding, skilled personnel, and companies pushing for better research methods to identify newer technologies for diagnosis & therapies, can be attributed to the significant adoption of CRISPR technology in this country.
In the U.S., CRISPR has rapidly gained popularity as a potential medical tool. In an ongoing clinical study by the University of Pennsylvania, initiated in January 2018, the first two patients had been treated using CRISPR; one patient had sarcoma and the other had multiple myeloma.
This study resulted in entry of CRISPR technology in the first human clinical trials in the U.S. Moreover, several clinical trials using CRISPR therapies are in the early stages of clinical development, especially across three treatment areas: cancer, eye disease, and blood disorders. Presence of several products in the preclinical pipeline is another factor that is expected to propel market growth.
Reasons to subscribe to U.S. crispr and cas genes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. crispr and cas genes market databook
-
Our clientele includes a mix of crispr and cas genes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. crispr and cas genes market , including forecasts for subscribers. This country databook contains high-level insights into U.S. crispr and cas genes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. crispr and cas genes market size, by product & service, 2018-2030 (US$M)
U.S. CRISPR And Cas Genes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
